Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease

• المؤلفون الرئيسيون: V. I. Ignatyeva (مؤلف), S. V. Moiseev (مؤلف), N. M. Bulanov (مؤلف), E. A. Karovajkina (مؤلف), A S. Moiseev (مؤلف)
• التنسيق: كتاب
• منشور في: IRBIS LLC, 2019-01-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Fabry disease (FD) is a severe lysosome storage disease caused by congenital deficiency of the enzyme α-galactosidase A and characterized by the risk of renal failure combined with cardiovascular and CNS complications. According to the currently available information, the early start of enzyme repla...